CPAP.com Leverages Wesper Technology to Expand At-Home Sleep Apnea Diagnostics

The landscape of sleep medicine is undergoing a significant shift as clinical-grade diagnostic tools migrate from controlled laboratory environments to the patient’s bedroom. This transition is exemplified by the recent push from CPAP.com to promote its At Home Sleep Test, powered by Wesper technology. By timing this initiative with Sleep Awareness Month, the company is addressing a critical gap in the healthcare market: the massive underdiagnosis of obstructive sleep apnea (OSA). Despite being the second most common sleep disorder globally, OSA remains hidden in millions of patients, often only coming to light after the development of secondary complications such as cardiovascular disease or, as noted by recent clinical observations, increased cancer risks.

The core of this development is the Wesper device, a sophisticated diagnostic tool that utilizes two medical-grade sensors to capture a comprehensive suite of biometric data. Unlike consumer-grade wearables that often rely on pulse oximetry or movement alone, the Wesper system measures breathing patterns, oxygen saturation, snoring intensity, and overall sleep architecture. This multi-sensor approach allows the device to deliver lab-quality insights that were previously only available through overnight polysomnography. The convenience of a two-night home study significantly lowers the barrier to entry for patients who may be deterred by the cost, discomfort, or waiting periods associated with traditional sleep labs.

“

This transition is exemplified by the recent push from CPAP.com to promote its At Home Sleep Test, powered by Wesper technology.

Beyond the hardware, the integration of a telehealth-driven physician review process represents a vital evolution in the medical device sector. The service model includes a professional evaluation of the data and, crucially, the ability to issue a prescription for treatment if the patient qualifies. This end-to-end workflow—from detection to prescription—streamlines the patient journey, moving them toward Continuous Positive Airway Pressure (CPAP) therapy or other interventions more rapidly than the traditional primary care referral model. For retailers like CPAP.com, this vertical integration not only serves a public health need but also creates a direct pipeline to their primary product offerings.